3Indexed trials
drug · Product Intelligence
Crenezumab
Pipeline Intelligence
Crenezumab: 3 indexed trials, 2 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.
2Sponsors
0Orange Book patent links
0FDA-linked events
Development evidence
NCT01723826Genentech, Inc. · alzheimersPHASE2
NCT03114657Hoffmann-La Roche · alzheimersPHASE3
NCT03491150Hoffmann-La Roche · alzheimersPHASE3
FDA / patent evidence
No FDA Orange Book product match is asserted for this intervention.
Regulatory context
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.